Enhanced Treatment

Pleural mesothelioma has been challenging to treat with limited options and a poor outlook. But, researchers have uncovered a promising new way to improve chemotherapy and radiotherapy. This exciting breakthrough means new treatment options for mesothelioma treatment. Understanding YB-1 in Mesothelioma A new study focused on a protein called Y-box-binding protein 1 (YB-1). Previous research has shown that YB-1 plays a role in controlling various aspects of pleural mesothelioma. It plays a role in cancer cell growth, cell death, and cell movement. Building on this knowledge, the researchers set out to see if targeting YB-1 could make treatments more effective. To target YB-1, the researchers used small interfering RNA to “knock down” YB-1. This significantly reduced tumor growth. This also…